tirzepatide 17.5mg Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Tirzepatide dosing guide with chart

503B outsourcing facility compounding of tirzepatide ended in early 2025

Of all demographic groups, women between the ages of 50 and 64 had the highest use rate: One in five women, or 20 percent, reported having ever used GLP-1 agonists

McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER

The following month-by-month breakdown reflects the general pattern our providers observe in a medically supervised program

Track your water intake throughout the day, especially in the early months when youre dealing with side effects like nausea or constipation

If you see markings up to 40 with a red cap, you have a U-40 syringe, which requires different calculations